PRL and pituitary tumor: Additionally, ACEIs and AT1R and AT2R inhibitors (losartan and PD 123177, respectively) caused decreased density of PRL-immunoreactive cells and PRL serum levels in estrogen-induced pituitary tumors [50,51].